Previous 10 | Next 10 |
home / stock / lmllf / lmllf news
Toronto, Ontario--(Newsfile Corp. - June 22, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedel...
Toronto, Ontario--(Newsfile Corp. - June 7, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company ") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelic...
Toronto, Ontario--(Newsfile Corp. - May 17, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company ") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelic...
PharmaDrug ([[LMLLF]]) enters into a supply agreement with an emerging Eurozone cannabis extractor for medical grade THC oil to be sold under the company's own brand. The company expects to receive product and begin selling in Germany by September of 2021.The company's lic...
Toronto, Ontario--(Newsfile Corp. - May 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company ") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelic...
Toronto, Ontario--(Newsfile Corp. - May 13, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psyc...
PharmaDrug ([[LMLLF]] +1.7%) has entered into a service agreement with a contract research organization ((CRO)) to evaluate the company's patented enteric-coated formulation of cepharanthine ("PD-001") in a broad panel of human cancers. The company also initiates the preclinical st...
Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelic...
PharmaDrug (LMLLF) company Sairiyo Therapeutics has been granted FDA Orphan Drug Designation ("ODD") to dimethyltryptamine ("DMT") for prevention of ischemia-reperfusion injury ("IRI") in patients undergoing solid organ transplantation.The ODD granted is broader than the company's origin...
Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychede...
News, Short Squeeze, Breakout and More Instantly...
2024-05-23 11:51:50 ET This company believes that the only viable way to produce a safe supply of street drugs is to develop biosynthetic versions of these substances to be manufactured domestically in a regulated %Pharmaceutical supply chain. The signing of a recent LOI could potential...
Toronto, Ontario--(Newsfile Corp. - May 23, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approved...
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a company that is forty-nine percent ...